Stocktoria
Jazz Pharmaceuticals plc JAZZ
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-01-18
Jazz Pharmaceuticals plc insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Smith Mark Douglas | director | 2026-06-15 | Sell | 1,157 | $230.55 |
| Patil Neena M | EVP & Chief Legal Officer | 2026-06-10 | Sell | 1,200 | $231.83 |
| GALA RENEE D | President & CEO | 2026-06-03 | Gift | 600 | — |
| COZADD BRUCE C | director | 2026-06-01 | Sell | 6,000 | $235.12 |
| Patil Neena M | EVP & Chief Legal Officer | 2026-05-28 | Sell | 1,192 | $236.97 |
| Pearce Samantha | EVP, Chief Commercial Officer | 2026-05-28 | Option exercise | 6,907 | $109.45 |
| Pearce Samantha | EVP, Chief Commercial Officer | 2026-05-28 | Sell | 6,907 | $235.41 |
| Mulligan Seamus | director | 2026-05-28 | Option exercise | 3,415 | $138.08 |
Source: SEC EDGAR filings · CIK 0001232524 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.